Researched by the Moat Check team. Every competitor was checked on a page we loaded, and the idea was scored with the same ten tests as every analysis. Spot something we missed? Add it below.
MOAT CHECK · RATING
No moat
“AI prior authorization for US medical practices: it reads the chart, fills out each insurer's form, submits the request by portal, fax or phone, and tracks it until approval.”
MOST LIKELY TO COPY → Waystar
Real pain and real budgets, but revenue cycle incumbents already ship the workflow to most US providers, and payer APIs arriving in 2027 will commoditise submission.
Most likely to copy
Waystar
Waystar already sells Authorization Manager, which uses AI to detect when auth is needed, submit requests and track status, to a revenue cycle base of 1M+ providers, so practices get it from a vendor they already use.
Time to replicate: Already shipped
Recommendation
Focus on one high-denial specialty and sell appeals and outcome guarantees, building a payer-by-payer denial and overturn dataset that improves approval rates in ways an RCM generalist will not prioritise.
Existing competitors
Companies already working on this or close to it.
Waystar Authorization Manager ↗Revenue cycle module that detects whether an order needs authorization, submits it with clinical documents and tracks status.70M authorization transactions a year (company site); 1M+ providers use Waystar
Develop Health ↗Prescription AI that extracts chart evidence, fills payer forms, submits by ePA, fax or phone and drafts appeals.
Moat Check is a research aid, not investment advice. Ratings reflect public information at the time of analysis.